AACR News: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants
April 8, 2013 · Comments Off
The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. The results of this preclinical work are presented at the AACR Annual Meeting 2013.
“It’s now a part of our family history”
April 23, 2012 · Comments Off
Blindsided by multiple cancer diagnoses in one year, family and friends decide to do something...
In partnership with the American Society of Clinical Oncology including University of Colorado Cancer Center...
Tortoise and the Hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
March 1, 2012 · Comments Off
3 Key Points Cancer cells rush through the steps of replication by depending on two...
Messersmith: We’re in the middle of a cancer revolution
June 7, 2011 · Comments Off
I take care of patients with gastrointestinal cancers in the clinic two days a week....
NIH grant funds search for colorectal cancer biomarkers
February 2, 2011 · Comments Off
University of Colorado Cancer Center researchers have received a $1.25 million grant to identify genetic...
The University of Colorado Cancer Center is enrolling patients in a clinical trial for a...
Colo. cancer patients win big as Gov. Ritter signs two patient access bills into law
May 17, 2010 · Comments Off
Cancer patients in Colorado scored a big win today as Colorado Gov. Bill Ritter signed...
Messersmith, UCCC gastrointestinal cancer program leader, talks about esophageal cancer
February 2, 2010 · Comments Off
Dr. Wells Messersmith, University of Colorado Cancer Center gastrointestinal cancer program leader and associate professor...
Bitter melon juice prevents pancreatic cancer in mouse models
February 2, 2010
7th Annual Learn About Cancer Day Returns to CU Cancer Center
February 25, 2015 · No comments
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colon cancer colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu enzalutamide fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Check out our own Christopher Korch! Congratulations on your profile in Science Mag! ow.ly/JPzYZ